ROLES OF FETUIN IN TUMORIGENESIS AND METASTASIS

$0U54FY2001CANIH

Meharry Medical College, Nashville TN

Investigators

Linked publications & trials

Paper 39669476 Paper 39257990 Paper 33690604 Paper 32973771 Paper 32922403 Paper 30059346 Paper 29567272 Paper 27852805 Paper 27444036 Paper 27356744 Paper 27253488 Paper 26878781 Paper 26597610 Paper 26321093 Paper 26246474 Paper 26078592 Paper 26045972 Paper 25972361 Paper 25637755 Paper 25593563 Paper 25258648 Paper 25078150 Paper 24833941 Paper 24332981 Paper 24259524 Paper 24155779 Paper 23875116 Paper 23720056 Paper 23543742 Paper 23449888 Paper 23338480 Paper 23010348 Paper 23000099 Paper 22496452 Paper 22295145 Paper 21995569 Paper 21768204 Paper 21738006 Paper 21727290 Paper 21668365 Paper 21656157 Paper 21525782 Paper 21486221 Paper 21311893 Paper 21287223 Paper 20932825 Paper 20806340 Paper 20404564 Paper 20173287 Paper 20173286 Paper 20173285 Paper 20173284 Paper 20173282 Paper 20173279 Paper 19690330 Paper 19474101 Paper 19341793 Paper 19277896 Paper 19164938 Paper 19047053 Paper 18987139 Paper 18838698 Paper 18761371 Paper 18707899 Paper 18485278 Paper 18409069 Paper 18325611 Paper 18296025 Paper 18289943 Paper 18238777 Paper 18193284 Paper 18065854 Paper 18021773 Paper 17932947 Paper 17803681 Paper 17720994 Paper 17606297 Paper 17194444 Paper 17184769 Paper 16891617 Paper 16891067 Paper 16850242 Paper 16638628 Paper 16504891 Paper 16484447 Paper 16288847 Paper 16248982 Paper 16108297 Paper 16022018 Paper 15987463 Paper 15737616 Paper 15734731 Paper 15695392 Paper 15670748 Paper 15313013 Paper 15111762 Paper 14991855 Paper 14758076 Paper 14644044 Paper 12932623

Abstract

Our long range goal is to understand the role of fetuin in tumorigenesis and metastasis. Fetuin is a approximately 50 kDa serum glycoprotein synthesized primarily by the liver. Its concentration is relatively high in the fetal blood compared to adult blood. Whereas its precise physiological function is not known, it has been shown to be important in bone formation, fetal brain development, and can support the growth of cells in vitro. We have shown that fetuin interacts specifically with matrix metalloproteinases and can activate the zymogen forms of MMP-2 and MMP-9. These enzymes are important in tumorigenesis and metastasis. The central hypothesis of this grant is that fetuin is able to localize matrix metalloproteinases on the surface of tumor cells and can activate the zymogen forms of MMP-2 and MMP-9. These enzymes are important in tumorigenesis and metastasis. The central hypothesis of this grant is that fetuin is able to localize matrix metalloproteinases on the surface of tumor cells and can modulate their activation process. The hypothesis will be tested by three specific aims: 1) Determine the mechanism by which fetuin modulates their activation process. The hypothesis will e tested by three specific aims: 1) Determine the mechanism by which fetuin modulates the activation of matrix metalloproteinases 2) To determine the motifs in fetuins which are responsible for interaction with matrix metalloproteinases and those responsible for cell surface binding and 3) To employ fetuin knockout mice to determine the role of fetuin in tumorigenesis and metastasis. In aim #1, immunoprecipitation and confocal microscopy will be used to colocalize MMP-3 and fetuin on the cell surface. To investigate the modulation of MMP-3 activity by fetuin, BIOTRACT matrix metalloproteinase assay will be used. For specific aim #2, Skatchard assays will be used to study the binding of fetuin to squamous and spindle cell carcinomas. Carbohydrate denuding enzymes will be used to assess the contribution of sugar moieties in the binding interactions.

View original record on NIH RePORTER →